Cargando…
In Silico Studies of Quinoxaline-2-Carboxamide 1,4-di-N-Oxide Derivatives as Antimycobacterial Agents
Molecular modelling studies were performed on some previously reported novel quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives (series 1–9). Using the LigandScout program, a pharmacophore model was developed to further optimize the antimycobacterial activity of this series of compounds. Using the...
Autores principales: | Radwan, Awwad A., Abdel-Mageed, Wael M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271882/ https://www.ncbi.nlm.nih.gov/pubmed/24566302 http://dx.doi.org/10.3390/molecules19022247 |
Ejemplares similares
-
Design, Synthesis, and Biological Evaluation of Novel Thiazolidinone-Containing Quinoxaline-1,4-di-N-oxides as Antimycobacterial and Antifungal Agents
por: Zhang, Heying, et al.
Publicado: (2020) -
Synthesis, Biological Evaluation, and In Silico Modeling of N-Substituted Quinoxaline-2-Carboxamides
por: Bouz, Ghada, et al.
Publicado: (2021) -
Novel Derivatives of Quinoxaline-2-carboxylic Acid 1,4-Dioxides as Antimycobacterial Agents: Mechanistic Studies and Therapeutic Potential
por: Frolova, Svetlana G., et al.
Publicado: (2023) -
Trypanocidal Activity of Quinoxaline 1,4 Di-N-oxide Derivatives as Trypanothione Reductase Inhibitors
por: Chacón-Vargas, Karla Fabiola, et al.
Publicado: (2017) -
New Amide Derivatives of Quinoxaline 1,4-di-N-Oxide with Leishmanicidal and Antiplasmodial Activities
por: Barea, Carlos, et al.
Publicado: (2013)